Carmichael Hill & Associates, Inc. - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 61 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Carmichael Hill & Associates, Inc. ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q3 2022$0
-100.0%
1,5000.0%0.00%
-100.0%
Q2 2022$1,000
-66.7%
1,5000.0%0.00%0.0%
Q1 2022$3,000
-50.0%
1,5000.0%0.00%
-66.7%
Q4 2021$6,000–1,500–0.00%–
 Download
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q4 2021
NameSharesValueWeighting ↓
AJ WEALTH STRATEGIES, LLC 36,001$00.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders